Jason Cohen, Editor

About the Author Jason Cohen, Editor


Viking Therapeutics (VKTX) Stock: Next Stop, $28?

Investors love biotech stocks for the lottery ticket-like returns they can offer if a company …

Analysts Bet Trevena’s (TRVN) Pain Management Drug Will Get FDA Approval

Every month brings plenty of catalysts for several biotech stocks. October is no exception. There …

This Analyst Just Doubled His Price Target on Viking Therapeutics (VKTX) Stock; Here’s Why

It’s a very rewarding trading day for investors in Viking Therapeutics (VKTX) with shares up …

Here’s Why Teva Pharmaceutical (TEVA) Stock Soared Today

There’s a new FDA-approved migraine treatment on the scene. On Friday night, the U.S. regulators green-lighted …

Maxim Stays Bullish on Atossa (ATOS) Stock Following Preliminary Phase 1 Results

In a research note issued Thursday, Maxim analyst Jason McCarthy reiterated a Buy rating on shares …

J.P. Morgan Cuts Price Target on Acorda (ACOR) Stock Following Negative Ruling on Ampyra Patent

Did an iceberg just wallop into Acorda (ACOR) stock? The drug maker’s shares are plunging at …

H.C. Wainwright Reiterates Upbeat View of MannKind; Here’s Why

This week, MannKind (MNKD) announced a global partnership with United Therapeutics (UTHR) to develop and …

Is Sangamo’s (SGMO) Stock Price Collapse Justified?

Sangamo’s (NASDAQ:SGMO) shares lost over a quarter of their value in the past two days, …

Oppenheimer Reiterates Bullish Stance on TherapeuticsMD (TXMD) Following Business Update

TherapeuticsMD (NYSE:TXMD) CEO Robert Finizio and Co-founder Brian Bernick presented today at the 13th Annual Wells Fargo Securities …